Health Care Equipment & Services

Explore how TransMedics CFO’s disciplined insider trades reveal liquidity strategy, market confidence, and growth potential in the transplant tech sector.

Insider sell‑to‑cover activity at TransMedics Group shows routine liquidity management, not a shift in confidence, amid strong biotech valuation and promising transplant‑therapy progress.

Insider buying at Cerus Corp signals leadership confidence amid market swings, spotlighting the company’s pathogen‑inactivation tech, growing reimbursement prospects, and potential upside for investors.

BrightSpring’s $40.96 insider sale of 20 M shares fuels growth plans, tech‑driven home‑care, and investor confidence amid a $819 M secondary offering.

Boston Scientific’s insider buying of deferred stock units signals board confidence in a rebound—insider buys, product wins, and a bullish outlook for investors.

Pulmonx insider trades reveal tax‑planning moves and RSU confidence; investors eye Q4 earnings to gauge if its VARDIS platform can lift a distressed stock.

Artivion insider buys reveal confidence in rare‑disease pipeline & potential price impact.

Progyny CFO’s insider buying signals confidence in the company’s fertility‑benefits growth model, offering investors a potential long‑term upside amid recent stock dips.

Discover how Evolent Health’s CEO and execs’ buy‑sell patterns reveal nuanced confidence, PSU stakes, and sector risks—insightful for investors.

Progyny execs buying shares & options—insider confidence signals an undervalued stock amid fertility‑benefit growth, clinic expansion & potential upside.